Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

NeuroBo Pharmaceuticals, Inc. NRBO

Set alert

Price alert · NRBO

All alert types
2.36 +2.36 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
20.33M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-1.39
Beta
-0.28
Short ratio
0.87
Inst. own
12.71%
Dividend
0.00
Ex-div date
Earnings
Nov 7, 2024
50-d avg
2.59
200-d avg
3.63
1y target
26.67

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for NRBO has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-13.17 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

0 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.3×
FY 2016: -25.0×FY 2017: -19.7×FY 2018: -29.1×FY 2019: -2.0×FY 2020: -2.9×FY 2021: -1.9×FY 2022: -0.3×FY 2023: -1.5×FY 2024: -0.7×FY 2025: -0.3×
FY 2016 5y median -0.7× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 782×
FY 2016: 17.7×FY 2017: 167×FY 2018: -1.1×FY 2019: 3.6×FY 2020: 11.8×FY 2021: 1.9×FY 2022: 0.1×FY 2023: 1.1×FY 2024: 23.1×FY 2025: 782×
FY 2016 5y median 1.9× FY 2025
P/FCF -265×
FY 2016: -33.0×FY 2017: -24.5×FY 2018: -3.9×FY 2019: -6.1×FY 2020: -7.9×FY 2021: -1.9×FY 2022: -0.2×FY 2023: -1.7×FY 2024: -7.4×FY 2025: -265×
FY 2016 5y median -1.9× FY 2025
EV/EBITDA 218829×
FY 2016: -23.5×FY 2017: -19.6×FY 2018: -8.7×FY 2019: -1.4×FY 2020: -2.5×FY 2021: -0.8×FY 2022: 2.8×FY 2023: 0.3×FY 2024: 8359×FY 2025: 218829×
FY 2016 5y median 2.8× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -0.4%
FY 2016: -3.0%FY 2017: -4.1%FY 2018: -25.5%FY 2019: -16.4%FY 2020: -12.6%FY 2021: -53.6%FY 2022: -634.3%FY 2023: -57.8%FY 2024: -13.5%FY 2025: -0.4%
FY 2016 5y median -53.6% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -243.3%
FY 2016: -70.7%FY 2017: -847.9%FY 2018: 31.0%FY 2019: -173.4%FY 2020: -412.0%FY 2021: -104.7%FY 2022: -64.2%FY 2023: -74.7%FY 2024: -347.9%FY 2025: -243.3%
FY 2016 5y median -104.7% FY 2025
ROIC -247.3%
FY 2016: -70.6%FY 2017: -236.9%FY 2018: -115.8%FY 2019: -162.6%FY 2020: -407.2%FY 2021: -104.3%FY 2022: -90.2%FY 2023: -94.1%FY 2024: -357.1%FY 2025: -247.3%
FY 2016 5y median -104.3% FY 2025
ROA -116.6%
FY 2016: -58.9%FY 2017: -175.7%FY 2018: -120.0%FY 2019: -147.3%FY 2020: -270.6%FY 2021: -91.0%FY 2022: -41.7%FY 2023: -54.7%FY 2024: -169.7%FY 2025: -116.6%
FY 2016 5y median -91.0% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 52.4%
FY 2016: -82.0%FY 2017: -125.4%FY 2018: 31.2%FY 2019: 11.5%FY 2020: -47.3%FY 2021: 48.5%FY 2022: -28.3%FY 2023: 19.1%FY 2024: -81.3%FY 2025: 52.4%
FY 2016 FY 2025
EPS (diluted) -106.5%
FY 2016: -47.4%FY 2017: -28.6%FY 2018: 93.1%FY 2019: -517.8%FY 2020: 57.4%FY 2021: 64.1%FY 2022: 88.0%FY 2023: 87.1%FY 2024: -44.7%FY 2025: -106.5%
FY 2016 FY 2025
Free Cash Flow 36.5%
FY 2016: -103.3%FY 2017: -143.6%FY 2018: 18.5%FY 2019: 66.9%FY 2020: -48.5%FY 2021: -40.6%FY 2022: 22.6%FY 2023: 7.4%FY 2024: -127.8%FY 2025: 36.5%
FY 2016 FY 2025

Financial Health

Current Ratio 1.9×
FY 2016: 6.0×FY 2017: 3.0×FY 2018: 2.0×FY 2019: 6.8×FY 2020: 2.9×FY 2021: 7.7×FY 2022: 2.8×FY 2023: 3.8×FY 2024: 1.9×FY 2025: 1.9×
FY 2016 5y median 2.8× FY 2025
Quick Ratio 1.9×
FY 2016: 6.0×FY 2017: 3.0×FY 2018: 2.0×FY 2019: 6.8×FY 2020: 2.9×FY 2021: 7.7×FY 2022: 2.8×FY 2023: 3.8×FY 2024: 1.9×FY 2025: 1.9×
FY 2016 5y median 2.8× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 2.2×FY 2018: -0.1×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -530×
FY 2016: 1.7×FY 2017: 0.3×FY 2018: 1.1×FY 2019: 0.7×FY 2020: 0.3×FY 2021: 1.1×FY 2022: 2.9×FY 2023: 1.8×FY 2024: -794×FY 2025: -530×
FY 2016 5y median 1.1× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -34.9×FY 2019: -917×FY 2020: -762×FY 2021: 0.0×FY 2022: -9.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31